Neurorescuex Hh333 Capsule
NDC Package 84074-001-03
Package Information
Neurorescuex Hh333 (scutellaria baicalensis root, coptis japonica root, phellodendron chinensis bark, gardenia jasminoides fruit, rheum palmatum root) capsules is ■ prevention of cerebrovascular diseases, cardiovascular disease ■ improvement of vascular endothelial cell function ■ adjunctive use to control hypertension, hyperlipidemia ■ weight loss support. This formulation utilizes a capsule delivery system. Marketed by Panacura Inc., this product is identified by NDC 84074-001.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 84074 - Panacura Inc.
- 84074-001 - Neurorescuex Hh333
- 84074-001-03 - 2 CARTON in 1 CARTON / 6 BLISTER PACK in 1 CARTON (84074-001-02) / 10 CAPSULE in 1 BLISTER PACK (84074-001-01)
- 84074-001 - Neurorescuex Hh333
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (84074-001). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84074-001-03 identifies a specific commercial package of 2 carton in 1 carton / 6 blister pack in 1 carton (84074-001-02) / 10 capsule in 1 blister pack (84074-001-01) of Neurorescuex Hh333, a human over the counter drug labeled by Panacura Inc.. This capsule is formulated for oral use and contains coptis japonica root; gardenia jasminoides fruit; phellodendron chinensis bark; rheum palmatum root; scutellaria baicalensis root as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Panacura Inc. on May 05, 2024. The current certification is valid through December 31, 2026.
How is this Panacura Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84074000103. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.